Antibody against Activin A approved by FDA to treat Fibrodysplasia Ossificans Progressiva

Former CBER head Peter Marks says he blocked RFK Jr. from vaccine safety database before leaving FDA

Zantac’s maker kept quiet about cancer risks for 40 years

JAMA Study: "Although prices are often justified by the high cost of drug development, there is no evidence of an association between research and development costs and prices; rather, prescription drugs are priced in the United States primarily on the basis of what the market will bear."

What price MS therapy? Thanks to price hikes, $50K-plus, even for decades-old meds